3’-O-t-Bulyldimethylsilylthymidine
3’-O-t-Bulyldimethylsilylthymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
[40733-27-5]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Nucleoside Antimetabolite/Analog
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/3-o-t-bulyldimethylsilylthymidine.html
Purity
99.04
Solubility
DMSO : ≥ 100 mg/mL
Smiles
OC[C@@H]1[C@@H](O[Si](C)(C)C(C)(C)C)C[C@H](N2C(NC(C(C)=C2)=O)=O)O1
Molecular Formula
C16H28N2O5Si
Molecular Weight
356.49
Precautions
H302, H315, H319, H335
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Telomeric repeat-binding Factor 2-interacting protein 1 (TERF2IP) Rat ELISA Kit
